HB3160 - Pharmaceutical Research Transparency Act of 2023
US Congress - 118th Congress
Introduced byJamie Raskin, Elissa Slotkin
Last updated over 1 year ago
2 Co-Sponsors
To amend the Public Health Service Act to increase the transparency of pharmaceutical research costs, and for other purposes.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now